Who
Donald P. Lehr
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Precigen.
In numbers
- Trades disclosed
- 124
- Buys
- 2
- Sells
- 22
- Bought
- $50K
- Sold
- $1.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Aug 2013
- Last trade
- 23 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —5,208 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code F | $18K2,488 at $7.20 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,208 at $0.00 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,208 at $0.00 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —5,208 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code F | $18K2,488 at $7.20 | filing |
| 28 May 2026filed 1 Jun 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $127K29,131 at $4.36 | filing |
| 28 May 2026filed 1 Jun 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Sold | $127K29,131 at $4.36 | filing |
| 23 May 2026filed 27 May 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —62,500 | filing |
| 23 May 2026filed 27 May 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —62,500 at $0.00 | filing |
| 23 May 2026filed 27 May 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —62,500 at $0.00 | filing |
| 23 May 2026filed 27 May 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —62,500 | filing |
| 20 Apr 2026filed 22 Apr 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —358,000 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,000 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —358,000 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,000 at $0.00 | filing |
| 18 Mar 2026filed 20 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —40,443 | filing |
| 18 Mar 2026filed 20 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,443 at $0.00 | filing |
| 18 Mar 2026filed 20 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —40,443 at $0.00 | filing |
| 18 Mar 2026filed 20 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,443 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.